LU83616A1 - N-((4-(pyridyl 3-substitue)piperazino)alkyl)azaspirodecanediones - Google Patents

N-((4-(pyridyl 3-substitue)piperazino)alkyl)azaspirodecanediones Download PDF

Info

Publication number
LU83616A1
LU83616A1 LU83616A LU83616A LU83616A1 LU 83616 A1 LU83616 A1 LU 83616A1 LU 83616 A LU83616 A LU 83616A LU 83616 A LU83616 A LU 83616A LU 83616 A1 LU83616 A1 LU 83616A1
Authority
LU
Luxembourg
Prior art keywords
compound
compound according
mammal
azaspiro
decane
Prior art date
Application number
LU83616A
Other languages
English (en)
French (fr)
Inventor
Joseph P Yevich
Davis L Temple
Walter G Lobeck
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of LU83616A1 publication Critical patent/LU83616A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU83616A 1980-09-08 1981-09-08 N-((4-(pyridyl 3-substitue)piperazino)alkyl)azaspirodecanediones LU83616A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18467780 1980-09-08
US06/184,677 US4305944A (en) 1980-09-08 1980-09-08 N-[(4-[3-cyano substituted pyridyl]piperazino)alkyl]-azaspirodecanediones

Publications (1)

Publication Number Publication Date
LU83616A1 true LU83616A1 (fr) 1982-04-14

Family

ID=22677905

Family Applications (1)

Application Number Title Priority Date Filing Date
LU83616A LU83616A1 (fr) 1980-09-08 1981-09-08 N-((4-(pyridyl 3-substitue)piperazino)alkyl)azaspirodecanediones

Country Status (23)

Country Link
US (1) US4305944A (sv)
JP (1) JPS5780381A (sv)
AT (1) AT378192B (sv)
AU (1) AU525584B2 (sv)
BE (1) BE890265A (sv)
CA (1) CA1196333A (sv)
CH (1) CH649084A5 (sv)
CY (1) CY1369A (sv)
DE (1) DE3135523A1 (sv)
DK (1) DK154647C (sv)
FI (1) FI70580C (sv)
FR (1) FR2489823A1 (sv)
GB (1) GB2083474B (sv)
GR (1) GR75756B (sv)
HK (1) HK4388A (sv)
IE (1) IE51548B1 (sv)
KE (1) KE3721A (sv)
LU (1) LU83616A1 (sv)
NL (1) NL8104144A (sv)
SE (1) SE442636B (sv)
SG (1) SG29987G (sv)
YU (2) YU42423B (sv)
ZA (1) ZA816214B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320131A (en) * 1981-03-16 1982-03-16 Mead Johnson & Company N-[(4-Phenyl-1,2,3,6-tetrahydropyridin-1-yl)alkylene]azaspiroalkanediones and N-[(4-hydroxy-4-phenylpiperidin-1-yl)alkylene]azaspiroalkanediones
US4507303A (en) * 1981-12-22 1985-03-26 Sumitomo Chemical Company, Limited Succinimide derivatives, compositions and method of use
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
US4656280A (en) * 1984-03-07 1987-04-07 E. I. Du Pont De Nemours And Company Radioiodinated dopamine receptor ligand
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4812567A (en) * 1985-10-16 1989-03-14 American Home Products Corporation Polycyclic spiroimides with psychotropic activity
US4797488A (en) * 1987-04-03 1989-01-10 American Home Products Corporation Psychotropic polycyclic imides
US4748240A (en) * 1987-04-03 1988-05-31 American Home Products Corporation Psychotropic bicyclic imides
HU212301B (en) * 1989-04-28 1996-05-28 Alkaloida Vegyeszeti Gyar Process for producing buspirone
US5162321A (en) * 1989-12-20 1992-11-10 Adir Et Compagnie 1-naphthyl piperazines useful as 5-HT1A receptor ligands
US20040077605A1 (en) 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method

Also Published As

Publication number Publication date
JPH0134226B2 (sv) 1989-07-18
FI70580B (fi) 1986-06-06
DK154647C (da) 1989-05-08
CA1196333A (en) 1985-11-05
FR2489823A1 (fr) 1982-03-12
BE890265A (fr) 1982-03-08
US4305944A (en) 1981-12-15
SG29987G (en) 1987-07-17
FI812736L (fi) 1982-03-09
FI70580C (fi) 1986-09-24
AT378192B (de) 1985-06-25
JPS5780381A (en) 1982-05-19
AU7502481A (en) 1982-03-18
YU213881A (en) 1984-02-29
ZA816214B (en) 1982-09-29
YU42423B (en) 1988-08-31
GB2083474B (en) 1984-05-31
GB2083474A (en) 1982-03-24
IE812069L (en) 1982-03-08
IE51548B1 (en) 1987-01-07
DK154647B (da) 1988-12-05
DK395081A (da) 1982-03-09
DE3135523A1 (de) 1982-06-16
NL8104144A (nl) 1982-04-01
FR2489823B1 (sv) 1985-01-11
HK4388A (en) 1988-01-29
DE3135523C2 (sv) 1990-06-07
ATA388181A (de) 1984-11-15
CH649084A5 (de) 1985-04-30
SE8105341L (sv) 1982-03-09
SE442636B (sv) 1986-01-20
YU213783A (en) 1984-02-29
CY1369A (en) 1987-08-07
GR75756B (sv) 1984-08-02
AU525584B2 (en) 1982-11-11
KE3721A (en) 1987-04-30

Similar Documents

Publication Publication Date Title
JP3880842B2 (ja) １−〔（４−クロロフェニル）フェニルメチル〕ピペラジンの鏡像体およびその製造法
EP0506532B1 (fr) Nouveaux dérivés de l'indole, procédé de préparation et médicaments les contenant
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
LU84011A1 (fr) 2-phenoxyalkyl-1,2,4-triazol-3-ones antidepressives
LU83616A1 (fr) N-((4-(pyridyl 3-substitue)piperazino)alkyl)azaspirodecanediones
LU85796A1 (fr) Derives antipsychotiques de la 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine
EP0934319B1 (fr) DERIVES DE 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
EP0350403A1 (fr) Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant
FR2510572A1 (fr) Nouvelles thiazolidinediones, leur procede de production et preparation pharmaceutique les contenant
EP1828125B1 (fr) Derives d'arylpiperazine et leur utilisation comme ligands selectifs du recepteur d3 de la dopamine
EP0351255B1 (fr) Dérivés de [(pipéridinyl-4)méthyl]-2 tétrahydro-1,2,3,4 isoquinoléine, leur préparation et leur application en thérapeutique
BE1009852A3 (fr) Derives 1-[2(vinyl-substitues)]-3-4-dihydro-5h-2,3-benzodiazepine.
EP0301936B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique
EP0364350B1 (fr) Dérivés de méthyl-4[(phényl-4 pipérazinyl-1)-2 éthyl]-5 thiazole, leur procédé de préparation et les compositions pharmaceutiques en contenant
FR2536398A1 (fr) Nouveaux composes heterocycliques
FR2480286A1 (fr) Nouveaux derives de theophyllinylmethyldioxolane, leurs procedes de preparation et leur application en therapeutique
EP0296048B1 (fr) Nouveaux dérivés de la pipérazinyl alkyl piperazine dione, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
LU86405A1 (fr) Derive antipsychotique du benzisothiazole s-oxyde
EP1659112A1 (fr) Dérivés d'arylpipérazine comme ligands sélectifs du récepteur D3 de la dopamine
FR2510571A1 (fr) Spirothiazolidinedione, son procede de production et preparation pharmaceutique la contenant
EP1023287B1 (fr) Derives de la 3-oxo-2(h)-1,2,4-triazine en tant que ligands des recepteurs 5ht1a
FI84348C (sv) Förfarande för framställning av terapeutiskt användbara pyrimidintrion derivat
US4760065A (en) Trifluoromethyl substituted tetracyclic quinazolin-ones having tranquilizing activity
CA2346506C (fr) Derives d'aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone comme agonistes du recepteur 5-ht1
FR2738823A1 (fr) Derives de 3-(omega-(4-(thieno(3,2-c)pyridin-4-yl)piperazin- 1-yl)alkyl)-3,4-dihydroquinolein-2(1h)-one,leur preparation et leur application en therapeutique